Solid Biosciences (SLDB) Restructuring Costs (2020 - 2023)

Solid Biosciences has disclosed Restructuring Costs across 3 years of filings, most recently posting -$63000.0 for Q2 2023.

• Restructuring Costs for Q2 2023 came in at -$63000.0, down 104.14% year-over-year; the trailing twelve-month figure through Dec 2023 was $5.6 million (down 22.05% YoY), and the FY2023 annual result was -$63000.0, down 100.88% from the prior year.
• Restructuring Costs came in at -$63000.0 for Q2 2023 at Solid Biosciences, down from $5.7 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $5.7 million in Q4 2022 to a low of -$63000.0 in Q2 2023.
• The 3-year median for Restructuring Costs is $1.7 million (2020), against an average of $2.3 million.
• Peak annual rise in Restructuring Costs reached 104.14% in 2023, while the deepest fall reached 104.14% in 2023.
• Solid Biosciences' Restructuring Costs stood at $1.9 million in 2020, then jumped by 191.05% to $5.7 million in 2022, then tumbled by 101.11% to -$63000.0 in 2023.
• The last three Restructuring Costs figures came in at -$63000.0 (Q2 2023), $5.7 million (Q4 2022), and $1.5 million (Q2 2022), per Business Quant data.